# Hip Fracture Surgery in GLP-1 Users: Complications Against Three BMI Groups

What a 232-patient hip fracture surgery study found about in-hospital complications and readmissions among patients already using a GLP-1.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/better-than-the-thin-controls-too
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Hip Fracture Surgery in GLP-1 Users: Complications Against Three BMI Groups

One hospital registry found fewer in-hospital complications among patients with obesity who were already using a GLP-1 before a hip fracture.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Overall complications, 58 patients per group · obesity, on a GLP-1 · 22.41% · normal weight · 55.17% · overweight · 51.72% · obesity, no GLP-1 · 60.34% · One hospital registry. Groups were matched, not randomized.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

People with obesity who had been on a GLP-1 medicine for at least six months had fewer in-hospital complications after hip fracture surgery in one hospital registry study. The study compared patient records, so it could not determine whether the medicine caused the difference [\[1\]](https://buythisglp.com/research/better-than-the-thin-controls-too#ref-1).

## Key takeaways

-   The study compared four matched groups of 58 patients each.
-   Overall in-hospital complications were reported in 22.41% of the GLP-1 group and 60.34% of patients with obesity who did not use a GLP-1. The other two comparison groups had rates of 55.17% and 51.72%.
-   The study detected differences in minor complications and hospital readmissions. It did not detect a significant difference in major complications or implant failure.

## What the study compared

Our guide to [GLP-1 use and hip fracture risk](https://buythisglp.com/research/half-the-fractures-two-in-a-thousand) covers whether fractures occur. This study looked at what happened after a fracture. The researchers used a prospective registry from a single institution covering 2014–2024. They matched patients by age, fracture pattern and other health conditions [\[1\]](https://buythisglp.com/research/better-than-the-thin-controls-too#ref-1).

## Complications and readmissions after surgery

Among patients with obesity, the overall in-hospital complication rate was 22.41% with GLP-1 use, compared with 60.34% without it (P < 0.001 across the four groups). The rates were 55.17% at normal weight and 51.72% with overweight. Minor complication rates were 17.24% with GLP-1 use, 48.28% with obesity and no GLP-1 use, 37.93% at normal weight and 51.72% with overweight. The differences across the four groups were statistically significant for both measures [\[1\]](https://buythisglp.com/research/better-than-the-thin-controls-too#ref-1).

The study reported higher readmission rates in the group with obesity that did not use a GLP-1: 17.24% at 30 days and 24.14% at 90 days. The analysis did not detect significant differences in major complications or implant failure [\[1\]](https://buythisglp.com/research/better-than-the-thin-controls-too#ref-1).

Matching leaves room for other explanations

The authors classified this as Level III evidence. With only 58 people in each group, a single patient represents about 1.7 percentage points. Matching helps account for measured differences, while other differences between patients can still affect the comparison [\[1\]](https://buythisglp.com/research/better-than-the-thin-controls-too#ref-1).

Our [guide to GLP-1 medicines before surgery](https://buythisglp.com/research/do-you-have-to-stop-a-glp1-before-surgery) addresses medication planning for procedures. This registry study recorded prior use at the time of injury and did not test starting or stopping treatment around surgery.

## Frequently asked

Does being on a GLP-1 make hip fracture surgery safer?

The registry found fewer overall in-hospital complications in people with obesity already using a GLP-1. The study could not determine whether the medicine caused that difference.

Which outcomes differed?

The study detected differences in minor complications and readmissions. It did not detect significant differences in major complications or implant failure.

How big was the study?

It included 232 patients at one institution, with 58 in each of four groups. The authors classified it as Level III evidence.

## Sources

1.  \[1\] Goldstein AR, Olson D, Leucht P, Tejwani N, Ganta A, Konda S, Egol KA (2025). Slimming the risks: GLP-1 receptor agonist therapy may reduce in-hospital complications and hospital readmission rates in patients with obesity undergoing hip fracture surgery European Journal of Orthopaedic Surgery & Traumatology. [PMID 40892123](https://link.springer.com/article/10.1007/s00590-025-04477-0)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
